66 related articles for article (PubMed ID: 32276412)
1. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract][Full Text] [Related]
2. Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours.
Martini C; Gamper EM; Wintner L; Nilica B; Sperner-Unterweger B; Holzner B; Virgolini I
Health Qual Life Outcomes; 2016 Sep; 14(1):127. PubMed ID: 27614762
[TBL] [Abstract][Full Text] [Related]
3. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
[TBL] [Abstract][Full Text] [Related]
4. Role of Diet in the Management of Carcinoid Syndrome: Clinical Recommendations for Nutrition in Patients with Neuroendocrine Tumors.
Artale S; Barzaghi S; Grillo N; Maggi C; Lepori S; Butti C; Bovio A; Barbarini L; Colombo A; Zanlorenzi L; Castiglioni E; Trojani A
Nutr Cancer; 2022; 74(1):2-11. PubMed ID: 33148022
[TBL] [Abstract][Full Text] [Related]
5. GEP-NET: Knowledge gaps in the recent ESMO Guidelines.
Jain A; Yip D
Ann Oncol; 2020 Sep; 31(9):1260-1261. PubMed ID: 32417221
[No Abstract] [Full Text] [Related]
6. [Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism].
Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
[TBL] [Abstract][Full Text] [Related]
7. Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms.
Albertelli M; Petolicchio C; Brasili S; Pogna A; Boschetti M; Luciano G; Campana D; Gay S; Veresani A; Ferone D; Vera L
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686803
[No Abstract] [Full Text] [Related]
8. Selected Parameters of Bone Turnover in Neuroendocrine Tumors-A Potential Clinical Use?
Strzelczyk J; Wójcik-Giertuga M; Strzelczyk JK; Seńkowska AP; Biernacki K; Kos-Kudła B
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510722
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1.
Modica R; Altieri B; D'Aniello F; Benevento E; Cannavale G; Minotta R; Liccardi A; Colao A; Faggiano A
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837874
[TBL] [Abstract][Full Text] [Related]
10. Bone Loss in Patients with Pancreatic Neuroendocrine Tumors.
Tong H; Wang M; Liu J; Guo C; Wang Z; Wang J; Chen X
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431178
[TBL] [Abstract][Full Text] [Related]
11. Bone phenotypes in multiple endocrine neoplasia type 1: survey on the MEN1 Florentine database.
Marini F; Giusti F; Iantomasi T; Cioppi F; Brandi ML
Endocr Connect; 2022 May; 11(5):. PubMed ID: 35324455
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine neoplasia and bone (Review).
Ghemigian A; Carsote M; Sandru F; Petca RC; Oproiu AM; Petca A; Valea A
Exp Ther Med; 2021 Nov; 22(5):1219. PubMed ID: 34584564
[TBL] [Abstract][Full Text] [Related]
13. Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis
Li M; Hao L; Li L; Liu L; Chen G; Jiang W; Xu W; Zhu C; Yao G; Fang S
Front Pharmacol; 2020; 11():1023. PubMed ID: 32754032
[TBL] [Abstract][Full Text] [Related]
14. Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors.
Altieri B; Di Dato C; Modica R; Bottiglieri F; Di Sarno A; Pittaway JFH; Martini C; Faggiano A; Colao A
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32276412
[TBL] [Abstract][Full Text] [Related]
15. Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms.
Kikut J; Jasińska A; Pobłocki J; Brodowski J; Małgorzata S
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32630081
[TBL] [Abstract][Full Text] [Related]
16. Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Laing E; Kiss N; Michael M; Krishnasamy M
Neuroendocrinology; 2020; 110(5):430-442. PubMed ID: 31550712
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.
Altieri B; Barrea L; Modica R; Bottiglieri F; de Cicco F; Muscogiuri G; Circelli L; Savarese G; Di Somma C; Savastano S; Colao A; Faggiano A
Endocrine; 2022 Feb; 75(2):623-634. PubMed ID: 34533768
[TBL] [Abstract][Full Text] [Related]
18. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with
Bergsma H; van Lom K; Raaijmakers MHGP; Konijnenberg M; Kam BLBLR; Teunissen JJM; de Herder WW; Krenning EP; Kwekkeboom DJ
J Nucl Med; 2018 Mar; 59(3):452-458. PubMed ID: 28775205
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.
Jiménez-Fonseca P; Carmona-Bayonas A; Martín-Pérez E; Crespo G; Serrano R; Llanos M; Villabona C; García-Carbonero R; Aller J; Capdevila J; Grande E;
Cancer Metastasis Rev; 2015 Sep; 34(3):381-400. PubMed ID: 26245646
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
